Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Study to evaluate the safety and performance of the Innovalve mitral valve replacement system
The study is a multi-center, First-In-Human, prospective, single arm early feasibility study to evaluate the safety and performance of the Innovalve mitral valve replacement system
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Innovalve TMVR System | Experimental | MV replacement with Innovalve MR system |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Innovalve MR system | Device | Innovalve MR system |
|
| Measure | Description | Time Frame |
|---|---|---|
| Absence of implant or delivery related serious adverse events at 30 days | Absence of implant or delivery related serious adverse events | 30 days |
| Measure | Description | Time Frame |
|---|---|---|
| Technical success | All of the below: i. Absence of procedural mortality; and ii. Successful access, delivery, and retrieval of the device delivery system; and iii. Successful deployment and correct positioning of the first intended device; and iv. Freedom from emergency surgery or reintervention related to the device or access procedure. | Procedure |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The Chaim Sheba Medical Center | Ramat Gan | 5265601 | Israel |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D008944 | Mitral Valve Insufficiency |
| ID | Term |
|---|---|
| D006349 | Heart Valve Diseases |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Procedural success | All of the following must be present: I. Deployment of the device II. Absence of major device or procedure related serious adverse events, including:
| 30 days |
| NYHA functional class | 30 days, 6, 12 months and annually up to 5 years |
| Six-minute walk test | 30 days, 6, 12 months and annually up to 5 years |
| Quality of life improvement (KCCQ-12) Kensas City Cardiomyopathy Questionnaire | 30 days, 6, 12 months and annually up to 5 years |
| Reduction in Mitral Regurgitation grade | 30 days, 6, 12 months and annually up to 5 years |